Adalimumab is safe and effective in re-inducing clinical remission after post-surgical relapse of Crohn's disease: A case report

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We present the case of a 36-year-old patient with ileo-colonic stricturing Crohn's disease that recurred after surgery, did not respond to maximal medical therapy and was only partially responsive to treatment with adalimumab administered subcutaneously. The patient underwent surgery following an episode of intestinal obstruction, revealing chronic, adhesive peritonitis, with the intestinal loops fixed strongly together, and a fibrotic stricture of the pre-anastomotic ileum. The numerous adhesions were carefully separated and the stenotic tract of ileum was resected. Following the resection the patient had an early clinical relapse, which was documented by abdominal ultrasound. The patient was, therefore, treated again with adalimumab: the new cycle of treatment achieved clinical and ultrasonographic remission of the disease. Despite the previous treatment, no side-effects occurred. © 2010 Editrice Gastroenterologica Italiana S.r.l.

Cite

CITATION STYLE

APA

Caprioli, F., Viganò, C., Botti, F., & Contessini-Avesani, E. (2010). Adalimumab is safe and effective in re-inducing clinical remission after post-surgical relapse of Crohn’s disease: A case report. Digestive and Liver Disease Supplements, 4(1), 14–17. https://doi.org/10.1016/S1594-5804(11)60006-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free